Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
"Switching from tamoxifen to an aromatase inhibitor may be one reason for the discrepant studies surrounding CYP2D6 and tamoxifen -- as information about whether a patient took an aromatase inhibitor after tamoxifen was not available in most of the prior studies."
"The results of this successful high-level international research collaboration are an important step forward in our quest to individualize breast cancer treatment and provide tailored care to women with breast cancer."
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
"CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8"
Matthew P Goetz, Vera Suman, Tanya L Hoskin, Michael Gnant, Martin Filipits, Stephanie Safgren et. al
Clinical Cancer Research, December 2012, doi: 10.1158/1078-0432.CCR-12-2153
Visit our Breast Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Nordqvist, Joseph. "Inability To Metabolize Tamoxifen Changes Breast Cancer Outcomes." Medical News Today. MediLexicon, Intl., 29 Dec. 2012. Web.
20 Apr. 2014. <http://www.medicalnewstoday.com/articles/254491>
Nordqvist, J. (2012, December 29). "Inability To Metabolize Tamoxifen Changes Breast Cancer Outcomes." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/254491.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.